Freshpet (FRPT)
(Real Time Quote from BATS)
$104.60 USD
0.00 (0.00%)
Updated Apr 25, 2024 12:54 PM ET
2-Buy of 5 2
D Value A Growth D Momentum C VGM
Income Statements
Fiscal Year end for Freshpet, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 767 | 595 | 425 | 319 | 246 |
Cost Of Goods | 516 | 409 | 263 | 186 | 132 |
Gross Profit | 251 | 186 | 162 | 133 | 114 |
Selling & Adminstrative & Depr. & Amort Expenses | 281 | 238 | 187 | 135 | 114 |
Income After Depreciation & Amortization | -30 | -52 | -25 | -2 | 0 |
Non-Operating Income | 13 | 2 | 0 | 0 | 0 |
Interest Expense | 14 | 5 | 3 | 1 | 1 |
Pretax Income | -32 | -55 | -28 | -3 | -1 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | -2 | -4 | -2 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -34 | -59 | -30 | -3 | -1 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -34 | -59 | -30 | -3 | -1 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 32 | -17 | 7 | 20 | 16 |
Depreciation & Amortization (Cash Flow) | 63 | 35 | 32 | 22 | 16 |
Income After Depreciation & Amortization | -30 | -52 | -25 | -2 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 48.16 | 46.19 | 42.93 | 39.76 | 35.95 |
Diluted EPS Before Non-Recurring Items | -0.70 | -1.29 | -0.69 | -0.08 | -0.04 |
Diluted Net EPS (GAAP) | -0.70 | -1.29 | -0.69 | -0.08 | -0.04 |
Fiscal Year end for Freshpet, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 215.42 | 200.62 | 183.33 | 167.52 |
Cost Of Goods | NA | 140.85 | 134.33 | 124.09 | 116.76 |
Gross Profit | NA | 74.58 | 66.29 | 59.24 | 50.76 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 59.68 | 73.37 | 76.00 | 72.27 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 14.90 | -7.08 | -16.76 | -21.51 |
Non-Operating Income | NA | 8.90 | 4.13 | 4.11 | 0.95 |
Interest Expense | NA | 3.45 | 4.15 | 3.33 | 3.17 |
Pretax Income | NA | 15.29 | -7.10 | -15.97 | -23.74 |
Income Taxes | NA | 0.00 | 0.07 | 0.07 | 0.07 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | -0.91 | -0.98 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 15.29 | -7.17 | -16.95 | -24.79 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 15.29 | -7.17 | -16.95 | -24.79 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 49.89 | 48.19 | 48.13 | 48.05 |
Diluted EPS Before Non-Recurring Items | NA | 0.31 | -0.15 | -0.35 | -0.52 |
Diluted Net EPS (GAAP) | NA | 0.32 | -0.15 | -0.35 | -0.52 |